RELMADA THERAPEUTICS, INC. (RLMD) Operating income 2016–2025
RELMADA THERAPEUTICS, INC. (RLMD) annual operating income history from SEC filings — each fiscal year as reported.
-$59.1MFY2025 · since FY2016: -$16.2M → -$59.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$59.1M | +29.6% |
| FY2024 | -$83.9M | +19.1% |
| FY2023 | -$103.7M | +35.7% |
| FY2022 | -$161.2M | -28.3% |
| FY2021 | -$125.7M | -106.6% |
| FY2020 | -$60.8M | -302.7% |
| FY2019 | -$15.1M | -118.4% |
| FY2018 | -$6.9M | +4.2% |
| FY2017 | -$7.2M | +55.5% |
| FY2016 | -$16.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice